EcoDrugPlus

Integrin Alpha-Iib

Ensembl ID : ENSELUG00000012377
Gene Symbol: LOC105023367
3 Cross references
191 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSELUG00000017712
Gene Symbol: ITGB3A
1 Cross references
204 Possible Orthologues:

Integrin Beta-1

Ensembl ID : ENSELUG00000003788
Gene Symbol: LOC105019428
3 Cross references
211 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSELUG00000006751
Gene Symbol: LOC105006835
3 Cross references
195 Possible Orthologues:

Integrin Beta-7

Ensembl ID : ENSELUG00000015229
Gene Symbol: LOC105017152
2 Cross references
149 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSELUG00000010469
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSELUG00000012349
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSELUG00000013544
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSELUG00000006744
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSELUG00000018949
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSELUG00000011177
Gene Symbol: ITGB7
1 Cross references
130 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSELUG00000003113
Gene Symbol: ITGB8
2 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).